177 related articles for article (PubMed ID: 10377195)
21. Synthesis and characterization of fluorescent and photoactivatable MIP-1alpha ligands and interactions with chemokine receptors CCR1 and CCR5.
Zoffmann S; Turcatti G; Galzi J; Dahl M; Chollet A
J Med Chem; 2001 Jan; 44(2):215-22. PubMed ID: 11170631
[TBL] [Abstract][Full Text] [Related]
22. CCL9/MIP-1gamma and its receptor CCR1 are the major chemokine ligand/receptor species expressed by osteoclasts.
Lean JM; Murphy C; Fuller K; Chambers TJ
J Cell Biochem; 2002; 87(4):386-93. PubMed ID: 12397598
[TBL] [Abstract][Full Text] [Related]
23. Identification of C-C chemokine receptor 1 (CCR1) as the monocyte hemofiltrate C-C chemokine (HCC)-1 receptor.
Tsou CL; Gladue RP; Carroll LA; Paradis T; Boyd JG; Nelson RT; Neote K; Charo IF
J Exp Med; 1998 Aug; 188(3):603-8. PubMed ID: 9687537
[TBL] [Abstract][Full Text] [Related]
24. Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis.
Topham PS; Csizmadia V; Soler D; Hines D; Gerard CJ; Salant DJ; Hancock WW
J Clin Invest; 1999 Dec; 104(11):1549-57. PubMed ID: 10587518
[TBL] [Abstract][Full Text] [Related]
25. Macrophage inflammatory protein-1.
Menten P; Wuyts A; Van Damme J
Cytokine Growth Factor Rev; 2002 Dec; 13(6):455-81. PubMed ID: 12401480
[TBL] [Abstract][Full Text] [Related]
26. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites.
Dieu MC; Vanbervliet B; Vicari A; Bridon JM; Oldham E; Aït-Yahia S; Brière F; Zlotnik A; Lebecque S; Caux C
J Exp Med; 1998 Jul; 188(2):373-86. PubMed ID: 9670049
[TBL] [Abstract][Full Text] [Related]
27. The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1alpha and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation.
Pease JE; Wang J; Ponath PD; Murphy PM
J Biol Chem; 1998 Aug; 273(32):19972-6. PubMed ID: 9685332
[TBL] [Abstract][Full Text] [Related]
28. Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice.
Broxmeyer HE; Cooper S; Hague N; Benninger L; Sarris A; Cornetta K; Vadhan-Raj S; Hendrie P; Mantel C
Ann Hematol; 1995 Nov; 71(5):235-46. PubMed ID: 7492626
[TBL] [Abstract][Full Text] [Related]
29. Macrophage inflammatory protein 1alpha enhances in a different manner adhesion of hematopoietic progenitor cells from bone marrow, cord blood, and mobilized peripheral blood.
Suehiro Y; Muta K; Umemura T; Abe Y; Nishimura J; Nawata H
Exp Hematol; 1999 Nov; 27(11):1637-45. PubMed ID: 10560911
[TBL] [Abstract][Full Text] [Related]
30. Macrophage inflammatory protein-1alpha uses a novel receptor for primitive hemopoietic cell inhibition.
Ottersbach K; Cook DN; Kuziel WA; Humbles A; Lu B; Gerard C; Proudfoot AE; Graham GJ
Blood; 2001 Dec; 98(12):3476-8. PubMed ID: 11719391
[TBL] [Abstract][Full Text] [Related]
31. TGFbeta1 selectively up-regulates CCR1 expression in primary murine astrocytes.
Han Y; Wang J; Zhou Z; Ransohoff RM
Glia; 2000 Mar; 30(1):1-10. PubMed ID: 10696139
[TBL] [Abstract][Full Text] [Related]
32. Distinct and overlapping direct effects of macrophage inflammatory protein-1 alpha and transforming growth factor beta on hematopoietic progenitor/stem cell growth.
Keller JR; Bartelmez SH; Sitnicka E; Ruscetti FW; Ortiz M; Gooya JM; Jacobsen SE
Blood; 1994 Oct; 84(7):2175-81. PubMed ID: 7919333
[TBL] [Abstract][Full Text] [Related]
33. Macrophage inflammatory protein 1alpha attenuates the toxic effects of temozolomide in human bone marrow granulocyte-macrophage colony-forming cells.
Clemons M; Watson A; Howell A; Chang J; Heyworth C; Lord B; Testa N; Dexter TM; Margison G
Clin Cancer Res; 2000 Mar; 6(3):966-70. PubMed ID: 10741722
[TBL] [Abstract][Full Text] [Related]
34. Role of C-C chemokine receptors 1 and 5 and CCL3/macrophage inflammatory protein-1alpha in the cutaneous Arthus reaction: possible attenuation of their inhibitory effects by compensatory chemokine production.
Yanaba K; Mukaida N; Matsushima K; Murphy PM; Takehara K; Sato S
Eur J Immunol; 2004 Dec; 34(12):3553-61. PubMed ID: 15517609
[TBL] [Abstract][Full Text] [Related]
35. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages.
Kaufmann A; Salentin R; Gemsa D; Sprenger H
J Leukoc Biol; 2001 Feb; 69(2):248-52. PubMed ID: 11272275
[TBL] [Abstract][Full Text] [Related]
36. Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors.
Gong X; Gong W; Kuhns DB; Ben-Baruch A; Howard OM; Wang JM
J Biol Chem; 1997 May; 272(18):11682-5. PubMed ID: 9115216
[TBL] [Abstract][Full Text] [Related]
37. Human LZIP binds to CCR1 and differentially affects the chemotactic activities of CCR1-dependent chemokines.
Ko J; Jang SW; Kim YS; Kim IS; Sung HJ; Kim HH; Park JY; Lee YH; Kim J; Na DS
FASEB J; 2004 May; 18(7):890-2. PubMed ID: 15001559
[TBL] [Abstract][Full Text] [Related]
38. Uncoupling of stem cell inhibition from monocyte chemoattraction in MIP-1alpha by mutagenesis of the proteoglycan binding site.
Graham GJ; Wilkinson PC; Nibbs RJ; Lowe S; Kolset SO; Parker A; Freshney MG; Tsang ML; Pragnell IB
EMBO J; 1996 Dec; 15(23):6506-15. PubMed ID: 8978677
[TBL] [Abstract][Full Text] [Related]
39. LD78beta, a non-allelic variant of human MIP-1alpha (LD78alpha), has enhanced receptor interactions and potent HIV suppressive activity.
Nibbs RJ; Yang J; Landau NR; Mao JH; Graham GJ
J Biol Chem; 1999 Jun; 274(25):17478-83. PubMed ID: 10364178
[TBL] [Abstract][Full Text] [Related]
40. Characterization of binding sites for chemokines MCP-1 and MIP-1alpha on human brain microvessels.
Andjelkovic AV; Pachter JS
J Neurochem; 2000 Nov; 75(5):1898-906. PubMed ID: 11032879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
